Global Biothrax Analysis 2025, Forecast To 2034
7 Mar, 2025
What Fueled The Previous Growth In The Biothrax Market?
The biothrax market has seen considerable growth due to a variety of factors.
• There has been remarkable growth in the biothrax market in the past few years. The market, which is worth $860 million in 2024, is expected to scale up to $930 million in 2025, growing at a compound annual growth rate (CAGR) of 8.9%.
This historical market expansion can be credited to incidents of bioterrorism, needs of the military and defense sectors, FDA's authorization of its use before and after exposure, storing for public health crises, and scientific advancements in the creation of vaccines.
What Can Be Expected from the Biothrax Market Size Evolve over the Forecast Period?
The biothrax market is expected to maintain its strong growth trajectory in upcoming years.
• We anticipate robust expansion in the biothrax market size over the next few years. It is projected to escalate to $1,300 million in 2029 with a compound annual growth rate (CAGR) of 8.6%.
The predicted growth over this period links to growing apprehensions about bioterrorism, heightened government defense budget, enlargement of worldwide biodefense programs, innovations in vaccine technology, and escalating public health readiness initiatives. The notable trends in this forecast period encompass enhanced government and military funding, enlargement of biodefense strategies, advancements in vaccine delivery systems, increased consciousness about bioterrorism threats, and strategic alliances and partnerships.
Which Key Drivers Are Propelling The Biothrax Market's Growth?
The escalating intake of meat is anticipated to propel the biothrax market's expansion in the future. Factors contributing to this rise in meat consumption include increased urbanization, growing income, changing diet preferences, and cultural practices that highlight meat as a vital source of protein and nutrition. BioThrax is utilized to immunize livestock against anthrax, a disease that is transmitted through contaminated meat, thereby guaranteeing meat product safety and shielding public health from zoonotic disease outbreaks. For example, the Food and Agriculture Organization of the United Nations (FAO) revealed in their June 2023 report that global meat production increased from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, a 1.96% hike. Specifically, the production of bovine meat worldwide escalated from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Therefore, the surging demand for meat is enhancing the biothrax market's growth. The Biothrax Market Expansion due to Rising Instances of Anthrax
How Is The Biothrax Market segmented?
The biothrax market covered in this report is segmented –
1) By Type: Live Vaccines, Cell Free Protective Antigen Vaccines
2) By Clinical Indication: Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis
3) By Application: Human Use, Animal Use
4) By End-User: Hospital, Clinics, Vaccination Centers, Other End-Users
What New Trends Are Influencing The Biothrax Market?
The primary trend in the BioThrax market is centered around strategic investments aimed at expanding production capabilities, broadening the market's geographic reach, and innovating advanced anthrax vaccines. These calculated investments assist clinical trials and ensure regulatory compliance, paving the way for companies to secure permissions across various nations, thereby making vaccines more accessible in regions that lack services. To illustrate, Emergent BioSolutions, a biotech enterprise based in the US, landed a crucial contract in January 2024, awarded by the U.S. Department of Defense (DoD). Worth up to $235.8 million, the contract is for supplying BioThrax (Anthrax Vaccine Adsorbed) for military applications. This deal signifies the persistent requirement for efficient anthrax vaccines within the U.S. military and showcases Emergent's enduring alliance with governmental bodies in supplying biodefense solutions.
Who Are the Key Players In The Biothrax Market?
Major companies operating in the biothrax market include:
• Emergent Bio-Solutions
What Is The Most Dominant Region In The Biothrax Market?
North America was the largest region in the biothrax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biothrax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.